Data Integrity: US FDA Seeks Dismissal Of CRO Semler’s Lawsuit For Lost Business

Contract research organization’s claims that agency improperly relied on a ‘suspect spreadsheet’ in taking actions that damaged its business are barred by sovereign immunity and exceptions to the Federal Tort Claims Act, FDA says; a federal judge in California will hear arguments on motions to dismiss Jan. 15.

Folder on lawyer table, closeup

More from Legal & IP

More from Pink Sheet